Managing Partner
Serica Partners
Shanghai, CHINA
Mr. Kewen Jin is a serial entrepreneur in China's life science industry. He is currently Managing Director of Nimbus Innoworks, a life science incubator based in Suzhou. He was previously General Manager of Charles River Lab’s China company. Mr. Jin has co-founded and served as CEO of several companies in CRO biotech and medical device. He is an advisor to Suzhou Biobay, a leading life science park in China. He served as advisor to several multinational pharmaceutical companies, investment and consulting firms and NGOs. He was a marketing and international operation executive with Wyeth from 1993 to 2000 , in the U.S. and in China. He was trained in medicine (Shanghai Jiaotong University), molecular biology (Rockefeller), and finance (Columbia). He was granted the 2005 Magnolia Award by the Shanghai government. He served as the founding Chair of the Shanghai CRO Association. He's a Board member for Bayhelix.

Emerging Opportunities in Global Markets

11:45 AM–5:00 PM Jun 4, 2018 (US - Eastern)

Room 253ABC, Level 2

Katherine AndersenHead of Healthcare Corporate Finance and East/Central Life Science atSilicon Valley Bank Mr. Michael ChanSenior Vice President atHong Kong Exchanges and Clearing Limited (HKEX) Helen ChenManaging Director, Head of L.E.K. China and Asia Life Sciences atL.E.K. Consulting Tony ChenPartner atJones Day Shanghei Joseph DamondExecutive Vice President, International Affairs atBiotechnology Innovation Organization Yuan-Hua DingExecutive Director and Head of External Science & Innovation atPfizer Inc. Monica H.Director, International Affairs atBiotechnology Innovation Organization Edward HuChief Financial Officer and Chief Investment Officers atWuXi AppTec Kewen JinManaging Partner atSerica Partners Alex JungPartner/Managing DIrector atEY-Parthenon Wei LiFounding Partner at6 Dimensions Capital Micah MackisonSenior VP for Corporate Development and Strategy atAssembly Biosciences Wendy PanBoard of Directors atBayHelix Donghui QinDirector of Innovation atFerring Pharmaceuticals Greg ScottFounder and Chairman atChinaBIO Group Victor ShiChairman atBayHelix Alan TurleyDeputy Assistant Secretary for China atU.S. Department of Commerce Jonathan WangSenior VP and Head of Business Development atZai Lab Lijun WuChief Scientific Officer and Senior VP R&D, Fosun Pharma USA atShanghai Henlius Biotech Haishan XiongSenior Vice President for Business Development atFountain Medical Development GE YanfengDirector-General of the Research Department of Social Development atDevelopment Research Center of the State Council (DRC) Debra YuManaging Director atChina Renaissance Securities (US) Inc.
None yet.